Tickerplace logo

Tickerplace

Kyverna Therapeutics, Inc. logo

KYTXKyverna Therapeutics, Inc.

KYTX Stock Price, Valuation & Chart | Kyverna Therapeutics, Inc.

Compare
$8.620+0.27 (+3.17%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyKYTX intrinsic valueKYTX calculated fair value vs price
OverviewFinancialsDividendsRatios

KYTX Historical price chart

KYTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization523.75M
PE Ratio-2.93
EPS-2.94
Trading Volume598.93K
Today's High/Low8.72/8.25
Dividend Yield0.00
52 Week High/Low13.67/3.55
Shares Outstanding60.80M
KYTX Financial Statement
KYTX Analyst ratings
KYTX Analysis & performance metrics

KYTX Company profile

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. Its lead product…

KYTX Management team

Management
Sham Dholakia DPHIL, M.D.
Chief Product Officer
Dan Maziasz
Chief Business Officer
Cara Bauer Ph.D.
Chief Human Resources Officer
Karen WalkerCTO
Chief Technology Officer
Ryan Jones M.B.A.CFO
Chief Financial Officer
Naji H. Gehchan M.B.A., M.D.
Chief Medical & Development Officer
Warner BiddleCEO
Chief Executive Officer & Director
Tom Van Blarcom Ph.D.
Senior Vice President & Head of Research
Total 8 executives

KYTX Frequently asked questions

What is Kyverna Therapeutics, Inc. (KYTX) Stock Price?

Current stock price of Kyverna Therapeutics, Inc. (KYTX) stock is $8.620. The stock price is +3.17% higher in the session. The intraday range can be seen from this page. Volume of Kyverna Therapeutics, Inc. (KYTX) stock is 598.93K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Kyverna Therapeutics, Inc. (KYTX) stock price going up or down today?

The stock price of Kyverna Therapeutics, Inc. (KYTX) can change with earnings, company news, and overall market sentiment. Kyverna Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Kyverna Therapeutics, Inc. stock expensive at its current price?

Whether Kyverna Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KYTX on this page is -2.93. EPS on this page is -2.94. Compare those figures with peers and growth expectations before deciding if the current Kyverna Therapeutics, Inc. price is justified.

How has the stock price of Kyverna Therapeutics, Inc. (KYTX) performed historically?

Historical performance for Kyverna Therapeutics, Inc. (KYTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KYTX reacted to past earnings and market events.

Should I buy Kyverna Therapeutics, Inc. (KYTX) stock, at this price?

Buying Kyverna Therapeutics, Inc. (KYTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.